Aarti Drugs share news, announcements and annual reports
NSE: AARTIDRUGSBSE: 524348Pharmaceuticals & BiotechnologySmall Cap
Aarti Drugs Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Sep 1993 on BSE, Sep 2003 on NSE
Last close ₹453.80up ₹18.60 (4.27%)BSE ₹453.80
Share price at the NSE close on 2 Nov 2026. Previous close ₹435.20.
2 Nov: open ₹445.00, high ₹463.50, low ₹441.95
52-week range of traded prices to 2 Nov 2026
₹318.95Low, 30 Mar 2026₹534.00High, 10 Nov 2025
- Next results date: the board meets on 3 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹4,142 Cr930th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 21.66
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.67
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.44%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 13.1%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 12.4%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.37
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 7,50,10732.6% delivered
Aarti Drugs share news and announcements
832 announcements, routine notices left out, newest first. Page 15 of 17.
Jan 2013
23 Jan · Board meeting
Inter -alia to: (1) Consider, approve and to take on record audited financial results and accounts for the quarter and nine months ended December 31, 2012. (2) Consider declaration of 2nd Interim Dividend, if any.
Nov 2012
1 Nov · Dividend
Board of Directors of the Company at its meeting held on October 31, 2012, has declared Interim dividend @ Rs. 3.00 (30%) per share for the financial year 2012-2013.
Oct 2012
22 Oct · Corporate action
Company has announced November 06, 2012 as the Record Date for the purpose of payment of interim dividend if any, declared. In case of approval of Interim Dividend by the Board of Directors, the Company will dispatch of dividend warrants on November 10, 2012.19 Oct · Board meeting
Inter-alia to : (1) Consider, approve and take on record audited financial results and accounts for the quarter and half year ended on September 30, 2012; (2) Consider declaration of Interim Dividend, if any.
Aug 2012
11 Aug · Results
6 Aug · Meeting
Register of Members of the Company shall be closed from August 22, 2012 to August 29, 2012 (Both days inclusive) for the purpose of Annual General Meeting to be held on August 29, 2012 and declaration of dividend. Further, in case of approval of Dividend by the Member at the Annual General Meeting, the Company shall dispatch dividend warrants on September 05, 2012.
Jul 2012
30 Jul · Board meeting
Inter-alia, to consider, approve and take on record the audited financial results and accounts for the quarter ended June 30, 2012.26 Jul · Management
Mr. Harshit M. SavIa, Jt. Managing Director of the Company has resigned from the position of Chief Financial Officer (CFO) with effect from July 06, 2012. Further, the Company has informed that Mr. Adhish P. Patil, has been appointed as Chief Financial Officer of the Company with effect from July 06, 2012.9 Jul · Updates
Amalgamation of Suyash Laboratories Limited (Transferor Company), being wholly owned subsidiary of Aarti Drugs Limited with Aarti Drugs Limited (Transferee Company), has been approved by the Bombay High Court on May 11, 2012. The Company has filed the Bombay High Court order with the Ministry of Corporate Affairs, Mumbai on July 06, 2012. On filing of the said orders the Amalgamation has become Operative from April 01, 2011 (Appointed Date).
Jun 2012
26 Jun · Board meeting
Inter-alia to: (1) Reconsider, approve and take on record the Audited Financial Results for the year ended March 31, 2012, post amalgamation of Suyash Laboratories Limited (Wholly-owned subsidiary of the Company) with the Company approved by the Bombay High Court on May 11, 2012, to be effective from April 01, 2011.
May 2012
26 May · Dividend
Board of Directors of the Company at its Meeting held on May 25, 2012 has declared Final dividend @ Rs. 3.00 ps.(30%) per share for the financial year 2011-2012.11 May · Board meeting
Inter-alia to: 1) consider, approve and take on record the audited financial results and accounts for the quarter and year ended on March 31, 2012. 2) Consider declaration of final Dividend, if any.
Feb 2012
3 Feb · Board meeting
Shri Chandrakant V. Gogri, Founder Chairman of the Company has indicated to retire as the Chairman & Director of the Company upon attaining age of 66 years on August 16, 2012. In view of the above, a meeting of the Board of Directors of the Company will be held on February 09, 2012, to consider and approve succession plan.2 Feb · Dividend
Board of Directors of the Company at its Meeting held on February 01, 2012 has declared Interim dividend @ Rs. 2/- (20%) per share for the financial year 2011-2012. The aforesaid Interim Dividend will be dispatched to registered members of the Company on February 10, 2012.
Jan 2012
23 Jan · Corporate action
Company has announced February 07, 2012 as the Record Date for the purpose of payment of interim dividend if any, declared. In case of approval of Interim Dividend by the Board of directors, the company will dispatch dividend warrants on February 10, 2012.23 Jan · Board meeting
Inter -alia to: (1) Consider , approve and to take on record audited financial results and accounts for the quarter and nine months ended December 31, 2011. (2) Consider declaration of interim Dividend , if any.
Dec 2011
Nov 2011
2 Nov · Board meeting
Inter-alia, to consider, approve and take on record the audited financial results and accounts for the quarter and half year ended September 30, 2011.
Jul 2011
29 Jul · Updates
At the meeting of the Board of Directors of the Company held on July 29, 2011, Scheme of Amalgamation of Suyash Laboratories Limited with the Company, has been approved subject to such requisite approvals including shareholders, and High Court. The "Appointed Date" for the said amalgamation has been fixed as April 01, 2011. Since Suyash Laboratories Limited is a wholly owned subsidiary of the Company, no equity shares would be required to be issued by the Company on account of the said amalgamation.29 Jul · Results
20 Jul · Board meeting
Inter alia, to consider, approve and take on record the audited financial results and accounts for the quarter ended June 30, 2011.4 Jul · Meeting
Register of Members of the Company shall be closed from July 16, 2011 to July 23, 2011 (Both days inclusive) for the purpose of Annual General Meeting to be held on July 23, 2011 and declaration of dividend. Further, in case of approval of Dividend by the Member at the Annual General Meeting, the Company shall dispatch dividend warrants on July 30, 2011.
Jun 2011
1 Jun · Dividend
Board of Directors of the Company at its meeting held on May 30, 2011 has recommended Final Dividend of Rs.2.5/- per share (25%) on 1,21,08,550 Equity shares of Rs.10/- each fully paid-up for the Financial year 2010-11.
May 2011
26 May · Dividend
Board of Directors of the Company at its meeting held on May 25, 2011 has recommended Final Dividend of Rs.2.50 ps (25%) per share for the Financial year 2010-11.16 May · Board meeting
Inter-alia to: 1) consider, approve and take on record the audited financial results and accounts for the quarter and year ended on March 31, 2011. 2) Consider declaration of final Dividend, if any.
Apr 2011
15 Apr · Results
Company will publish audited financial results for the financial year 2010-11 within 60 days i.e. on or before May 30, 2011. In view of the above the Company will not publish Unaudited financial Result for the last quarter i.e. March 31, 2011.
Mar 2011
9 Mar · Management
Aarti Drugs Limited. has informed the Exchange that Mr. Harshit M. Savla, Jt. Managing Director of the Company has resigned from the position of Compliance Officer with effect from February 21, 2011. Company has further informed that Mr. Sunny D. Pagare, has been appointed as Company Secretary & Compliance Officer of the Company with effect from February 21, 2011